AstraZeneca (AZN)

Add to Watchlists
Create an Alert
63.49 -0.04  -0.06% NYSE Apr 17, 8:00PM BATS Real time Currency in USD

AstraZeneca Cash from Investing (Quarterly):

-1.004B for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

AstraZeneca Cash from Investing (Quarterly) Chart

Export Data
Save Image

AstraZeneca Historical Cash from Investing (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 -1.004B
Sept. 30, 2013 -647.00M
June 30, 2013 -874.00M
March 31, 2013 -364.00M
Dec. 31, 2012 -514.00M
Sept. 30, 2012 -2.698B
June 30, 2012 760.00M
March 31, 2012 593.00M
Dec. 31, 2011 -3.58B
Sept. 30, 2011 1.272B
June 30, 2011 186.00M
March 31, 2011 100.00M
Dec. 31, 2010 -452.00M
Sept. 30, 2010 258.00M
June 30, 2010 -925.00M
March 31, 2010 -1.107B
Dec. 31, 2009 -1.904B
Sept. 30, 2009 -410.00M
June 30, 2009 -236.00M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
   
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

AZN Cash from Investing (Quarterly) Benchmarks

Companies
GlaxoSmithKline 2.955B
Pfizer 80.00M
Johnson & Johnson -1.578B

AZN Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -3.58B Dec 2011
Maximum 1.272B Sep 2011
Average -607.68M
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.